Design, Synthesis and Structure-Activity Relationship Studies of Nicotinamide Derivatives as Potent Antifungal Agents by Disrupting Cell Wall. 2023

Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 1239 Siping Road, Shanghai 200092, China.

Fungal infections pose a serious challenge to human health due to the limited paucity of antifungal treatments. Starting as a hit compound screened from our compound library, a series of nicotinamide derivatives have been successfully synthesized via a facile one-step coupling reaction of aromatic carboxylic acid and amine. The synthesized compounds were evaluated for their antifungal activity against Candida albicans SC5314. Among the 37 nicotinamide derivatives screened, compound 16g was found to be the most active against C. albicans SC5314, with an MIC value of 0.25 μg/mL and without significant cytotoxicity. The rudimentary structure-activity relationships study revealed that the position of the amino and isopropyl groups of 16g was critical for its antifungal activity. In particular, compound 16g showed potent activity against six fluconazole-resistant C. albicans strains with MIC values ranging from 0.125-1 μg/mL and showed moderate activity against the other seven species of Candida, three strains of Cryptococcus neoformans, and three strains of Trichophyton. Furthermore, compound 16g showed fungicidal, anti-hyphal, and anti-biofilm activities in vitro, which were related to its ability to disrupt the cell wall of C. albicans. Taken together, 16g is a promising compound that is fungal-specific by targeting the cell wall and could be used as a lead compound for further investigation.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858

Related Publications

Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
January 2017, Bioorganic & medicinal chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
October 2021, Journal of agricultural and food chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
November 2016, European journal of medicinal chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
August 2012, European journal of medicinal chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
August 2022, Molecules (Basel, Switzerland),
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
June 2014, Journal of medicinal chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
September 2019, European journal of medicinal chemistry,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
February 2018, Bioorganic & medicinal chemistry letters,
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
June 2023, Antibiotics (Basel, Switzerland),
Tingjunhong Ni, and Fei Xie, and Liping Li, and Yumeng Hao, and Xiaochen Chi, and Lan Yan, and Dazhi Zhang, and Yuanying Jiang, and Quanzhen Lv
September 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!